11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadet, JL; Darwin, WD; Herning, RI; Huestis, MA; Karschner, EL; Lowe, RH; Schwilke, EW | 1 |
| Gruber, AJ; Hudson, JI; Huestis, MA; Pope, HG; Yurgelun-Todd, D | 1 |
2 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and Cognition Disorders
| Article | Year |
|---|---|
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Topics: Biomarkers; Cognition Disorders; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Smoking; Substance Abuse Detection; Substance-Related Disorders | 2009 |
Neuropsychological performance in long-term cannabis users.
Topics: Adolescent; Adult; Cognition Disorders; Comorbidity; Dronabinol; Female; Humans; Male; Marijuana Abuse; Memory Disorders; Middle Aged; Neuropsychological Tests; Regression Analysis; Research Design; Severity of Illness Index; Substance Abuse Detection; Time Factors; Verbal Learning | 2001 |